Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia
Clinical trial NCT00862992 · COMPLETED
Trial details
- NCT number
- NCT00862992
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2009-09-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.